H J T Rutten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
H J T Rutten has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Grard AP Nieuwenhuijzen
Dept. of Surgery, Catharina Hospital Eindhoven
7 shared publications - Cornelis J. H. van de Velde
Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
4 shared publications E. Bastiaannet
2 shared publications- F. Daams
Department of Surgery, VU Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
2 shared publications - G.J. Creemers
Department of Medical Oncology, Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands
2 shared publications - Gelde Arie Pieter Nieuwenhuijzen
Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands
2 shared publications
Latest Publications
- 20 November 2015
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (2) , 273-280
Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline
- 20 November 2015
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 42 (2) , 273-280
Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S115
289. Is multi-modality treatment in elderly patients with locally advanced rectal cancer safe?
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S115
289. Is multi-modality treatment in elderly patients with locally advanced rectal cancer safe?
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S99
242. Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S99
242. Modern treatment of rectal cancer closes the gap between common adenocarcinoma and mucinous carcinoma
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S46
97. Intraoperative red blood cell salvage in locally recurrent rectal cancer patients
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S46
97. Intraoperative red blood cell salvage in locally recurrent rectal cancer patients
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S25
41. The influence of delaying surgery for esophageal adenocarcinoma after neoadjuvant chemoradiotherapy on postoperative outcome
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S25
41. The influence of delaying surgery for esophageal adenocarcinoma after neoadjuvant chemoradiotherapy on postoperative outcome
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S19-S20
26. Emergency stoma placement in advanced rectal cancer: A practical guideline
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S19-S20
26. Emergency stoma placement in advanced rectal cancer: A practical guideline
- 1 May 2013
- Vol. 71 (4) , 209-14
The standardised mortality ratio is unreliable for assessing quality of care in rectal cancer.
The standardised mortality ratio (SMR) for rectal or anal cancer was above average in a large tertiary referral centre for locally advanced rectal cancer in the Netherlands. The aim of this study was to investigate whether the increased SMR was indeed related to poor quality of care or whether it could be explained by inadequate adjustment for case-mix factors. Between 2006 and 2008, 381 patients were admitted for rectal or anal cancer. The SMR score of this diagnostic group was 230 (95% CI 140 to 355), corresponding with 20 in-hospital deaths. The hospital dataset was merged with data from the Eindhoven Cancer Registry to obtain more detailed information. Patients admitted for palliative care only accounted for 45% (9/20) of the in-hospital mortality. In contrast to the high SMR, postoperative mortality was low, i.e. 2.6%. The majority of the rectal or anal cancer patients were diagnosed in and referred from another hospital. Referred patients more often had an advanced tumour stage, more often underwent resection and were more frequently treated with chemotherapy and/or radiotherapy than non-referred patients (p<0.01). Postoperative mortality rates for referred and non-referred patients were 2.9% and 1.9%, respectively. The increased SMR appeared to be caused by the admission of patients who received palliative care only. Consequently, the SMR is unreliable for the assessment of quality of care in patients with rectal or anal cancer.
- 1 May 2013
- Vol. 71 (4) , 209-14
The standardised mortality ratio is unreliable for assessing quality of care in rectal cancer.
The standardised mortality ratio (SMR) for rectal or anal cancer was above average in a large tertiary referral centre for locally advanced rectal cancer in the Netherlands. The aim of this study was to investigate whether the increased SMR was indeed related to poor quality of care or whether it could be explained by inadequate adjustment for case-mix factors. Between 2006 and 2008, 381 patients were admitted for rectal or anal cancer. The SMR score of this diagnostic group was 230 (95% CI 140 to 355), corresponding with 20 in-hospital deaths. The hospital dataset was merged with data from the Eindhoven Cancer Registry to obtain more detailed information. Patients admitted for palliative care only accounted for 45% (9/20) of the in-hospital mortality. In contrast to the high SMR, postoperative mortality was low, i.e. 2.6%. The majority of the rectal or anal cancer patients were diagnosed in and referred from another hospital. Referred patients more often had an advanced tumour stage, more often underwent resection and were more frequently treated with chemotherapy and/or radiotherapy than non-referred patients (p<0.01). Postoperative mortality rates for referred and non-referred patients were 2.9% and 1.9%, respectively. The increased SMR appeared to be caused by the admission of patients who received palliative care only. Consequently, the SMR is unreliable for the assessment of quality of care in patients with rectal or anal cancer.